23 results
Thumbnail

D2.413 - Diagnostic Value of the Basophil Degranulation Test in High-Risk Drug-Induced Anaphylaxis

Thumbnail

D2.415 - DRESS Syndrome induced by Lenalidomide

Thumbnail

D2.407 - Treating Through in Pediatric Patients: A Single-Center Experience

Thumbnail

D2.408 - Hypersensitivity Reactions to Corticosteroids: A Retrospective Cohort Study

Thumbnail

D2.414 - Diagnostic Distribution of Patch, Delayed-Reading Intradermal, and Drug Provocation Tests in Delayed-Type Cutaneous Drug Hypersensitivity

Thumbnail

D2.416 - Skin reaction to Kaftrio/Kalydeco (CFTR) in cystic fibrosis: safe reintroduction using an outpatient desensitization protocol

Thumbnail

D2.418 - Tolperisone Hypersensitivity: An Underrecognized Drug Allergy in the Context of Widespread Off-Label Use

Thumbnail

D2.419 - DRESS syndrome in the context of carbamazepine treatment - case report

Thumbnail

D2.420 - A challenging case of cardiotoxicity following palbociclib therapy

Thumbnail

D3.121 - Evaluation of small airway dysfunction in severe asthma treated with anti-IgE and anti-eosinophilic therapies: A prospective comparative study

Thumbnail

D3.109 - Clinical Characteristics of Asthma Patients with Fungal Sensitization: A Retrospective Cross-Sectional Study

Thumbnail

D3.110 - Patterns of Opioid or Neuromodulator Use in Chronic Cough Patients with Newly Diagnosed Asthma

Thumbnail

D3.111 - The Impact of War on the Course of Asthma

Thumbnail

D3.112 - Clinical Characteristics and Evaluation of Serum Inflammatory Markers in Patients Hospitalized Due to Asthma Exacerbations

Thumbnail

D3.113 - The Diagnostic Value of Exercise Bronchial Provocation Testing in Pediatric Asthma

Thumbnail

D3.114 - Characterization on genome-wide profile of H3K4me2 histone methylation in mouse asthmatic lung induced by Alt a 1

Thumbnail

D3.115 - Iloprost Attenuates Neutrophilic Airway Inflammation in a Murine Model of Type 2-Low Asthma

Thumbnail

D3.119 - Saving the Caregiver: Humanitarian Access to Dupilumab in a Physician with Severe Non-Allergic T2 Asthma in a Frontline Ukrainian City

Thumbnail

D3.120 - Delivering Severe Asthma Care in the Real World: Insights into Anti-TSLP (Tezepelumab) Use from a Tertiary Allergy and Respiratory Centre

Thumbnail

D3.122 - Real-World Outcomes Of Tezepelumab In Severe Asthma After 12 Months Of Treatment